| Financial Year |
March 31 2023 |
| Monetary Funds |
764,332,434.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
147,393,886.60 |
| Accounts Receivable |
1,096,110,251.07 |
| Advances to Suppliers |
39,868,237.74 |
| Other Receivables |
43,735,449.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
894,537,077.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,293,653.58 |
| Total Current Assets |
3,226,957,240.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
50,313,838.34 |
| Investment Properties |
-- |
| Fixed Assetes |
1,570,898,069.69 |
| Under-construction Projects |
430,595,565.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
327,904,620.92 |
| R&D expenses |
-- |
| Goodwill |
103,949,701.36 |
| Long-Term Deferred and Prepaid Expenses |
245,034,715.25 |
| Deferred Income Tax Assets |
127,212,758.59 |
| Other Non-Current Assets |
48,272,640.29 |
| Sub-Total of Non-Current Assets |
3,054,827,130.24 |
| Total Assets |
6,281,784,370.45 |
| Short-Term Loans |
1,222,337,260.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
267,952,654.55 |
| Accounts Payable |
1,000,785,085.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
65,586,511.19 |
| Taxes Payable |
15,818,709.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,648,713.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
69,489,111.21 |
| Other Current Liabilities |
70,787,244.34 |
| Sub-Total of Current Liabilities |
2,752,750,052.50 |
| Long-term Loans |
522,631,563.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
49,004.59 |
| Deferred Income Tax Liabilities |
72,954,457.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
895,405,876.04 |
| Total Liabilities |
3,648,155,928.54 |
| Paid-In Capital(Or Share Stock) |
507,941,948.00 |
| Capital Surplus |
753,763,899.21 |
| Surplus Reserve |
134,374,102.44 |
| LESS:Treasury Stock |
17,222,000.00 |
| Undistributed Profits |
1,124,969,054.23 |
| Minority Stockholder's Interest |
96,578,102.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,537,050,339.10 |
| Owner's Equity（Stockholder's Equity） |
2,633,628,441.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,281,784,370.45 |
